+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Transport of methotrexate and folates by multidrug resistance protein 3 and MRP1 Effect of polyglutamylation on MTX transport



Transport of methotrexate and folates by multidrug resistance protein 3 and MRP1 Effect of polyglutamylation on MTX transport



Cancer Research 61(19): 7225-7232



We have recently determined that human multidrug resistance protein (MRP) 3, which confers resistance to certain natural product agents and methotrexate (MTX), is competent in the MgATP-energized transport of MTX and the monoanionic bile constituent glycocholate as well as several glutathione and glucuronate conjugates. Of these capabilities, the facility of MRP3 in conferring resistance to and mediating the transport of MTX is of particular interest because it raises the possibility that this pump is a component of the previously described cellular efflux system for this antimetabolite. However, if this is to be the case, a critical property of cellular MTX efflux that must be addressed is its ability to mediate the export of MTX but not that of its intracellular polyglutamylated derivatives. Here we examine the role of MRP3 in these and related processes by determining the selectivity of this transporter for MTX, MTX polyglutamates, and physiological folates. In so doing, we show that MRP3 is not only active in the transport of MTX but is also active in the transport of the physiological folates folic acid (FA) and N5-formyltetrahydrofolic acid (leucovorin) and that polyglutamylation of MTX abolishes transport. Both FA and leucovorin are subject to high-capacity (Vmax(FA), 1.71 +- 0.05 nmol/mg/min; Vmax(leucovorin), 3.63 +- 1.20 nmol/mg/min), low-affinity (Km(FA), 1.96 +- 0.13 mM; Km(leucovorin), 1.74 +- 0.65 mM) transport by MRP3. Addition of a single glutamyl residue to MTX is sufficient to diminish transport by >95%. We also show that polyglutamylation similarly affects the capacity of MRP1 to transport MTX and that physiological folates are also subject to MgATP-stimulated transport by MRP1. On the basis of the capacity to transport MTX but not MTX-Glu2, it is concluded that MRP3 and MRP1 represent components of the previously described cellular efflux system for MTX. The capacity of MRP3 to transport folates indicates that it may reduce intracellular levels of these compounds and thereby indirectly influence antifolate cytotoxicity, and it also implies that this pump may play a role in the response to chemotherapeutic regimens in which leucovorin is a component.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 035978132

Download citation: RISBibTeXText


Related references

Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport. Cancer Research 61(19): 7225-7232, 2001

Mechanistic differences between GSH transport by multidrug resistance protein 1 (MRP1/ABCC1) and GSH modulation of MRP1-mediated transport. Molecular Pharmacology 74(6): 1630-1640, 2008

Peptide transport by the multidrug resistance-associated protein MRP1. Proceedings of the American Association for Cancer Research Annual Meeting 40: 668, 1999

Peptide transport by the multidrug resistance protein MRP1. Cancer Research 61(6): 2552-2557, 2001

Transport of leukotriene C4 by a cysteine-less multidrug resistance protein 1 (MRP1). Biochemical Journal 370(Pt 1): 357-360, 2002

Verapamil stimulates glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1). Journal of Pharmacology and Experimental Therapeutics 293(2): 530-538, 2000

Bioflavonoid stimulation of glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1). Drug Metabolism and Disposition 31(1): 11-15, 2003

Bioflavonoid stimulation of glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1). Drug Metabolism and Disposition: the Biological Fate of Chemicals 31(1): 11-15, 2002

Transport of methotrexate and E217betaG by ABCG2 Effects of variation at amino acid position 482 and polyglutamylation on methotrexate transport. Proceedings of the American Association for Cancer Research Annual Meeting 44: 113, 2003

Folates provoke cellular efflux and drug resistance of substrates of the multidrug resistance protein 1 (MRP1). Cancer ChemoTherapy and Pharmacology 73(5): 911-917, 2014

A molecular understanding of ATP-dependent solute transport by multidrug resistance-associated protein MRP1. Cancer Metastasis Reviews 26(1): 15-37, 2007

ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1. British Journal of Pharmacology 126(3): 681-688, 1999

Monomethylarsenic diglutathione transport by the human multidrug resistance protein 1 (MRP1/ABCC1). Drug Metabolism and Disposition: the Biological Fate of Chemicals 39(12): 2298-2304, 2012

Verapamil-stimulated glutathione transport by the multidrug resistance-associated protein (MRP1) in leukaemia cells. Biochemical Pharmacology 62(4): 417-424, 2001

Lignans and norlignans inhibit multidrug resistance protein 1 (MRP1/ABCC1)-mediated transport. Anticancer Research 30(11): 4423-4428, 2011